Frequency of Drug-Induced Hepatotoxicity in Patients with HIV/Tuberculosis Coinfection Receiving Antiretroviral and Anti-Tuberculosis Therapy
Pakistan Journal of Medical Sciences · 21.11.2026 · 42 (12) · 3686-3689
DOI: 10.12669/pjms.42.12.19876 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Journal of Medical Sciences, online erschienen am 21.11.2026. Verfasst von Sehrish Akbar und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
To evaluate the frequency of drug-induced hepatotoxicity in people with HIV/tuberculosis coinfection undergoing concurrent antiretroviral therapy (ART) and anti-tuberculosis treatment (ATT).Methodology: This was a case series of 140 adults aged 20-70 years patients diagnosed with HIV infection and had pulmonary tuberculosis who presenting to Allama Iqbal Teaching Hospital, Dera Ghazi Khan. The participants were recruited consecutively. Before treatment and after three months of ATT and ART, liver function tests were obtained. Drug-induced hepatotoxicity was observed based on predefined clinical and biochemical parameters. Data were processed in SPSS version 25; post-stratification chi-square tests were performed. A p-value ≤0.05 was considered statistically significant.
Results
Mean age was 42.6±11.3 years; 82 (58.6%) participants were men. Hepatotoxicity was seen due to drugs in 38/140 (27.1%). Hepatotoxicity was more common in patients with diabetes compared to patients without diabetes (57.1% vs 19.6%, p=0.01) and in the obese patients compared to non-obese patients (51.4% vs 19.0%, p=0.02). The most common symptoms were nausea (60.5%), and anorexia (52.6%). Age and sex were not significantly associated with hepatotoxicity.
Conclusion
Hepatotoxicity caused by drugs was seen in approximately one-quarter of patients with HIV/TB coinfection receiving ART and ATT simultaneously. Diabetes mellitus and obesity were significantly associated with hepatotoxicity. Early diagnosis and treatment of liver injury may be facilitated by baseline assessment of metabolic comorbidity and routine liver-function testing, especially in the early course of treatment.
Zitieren
APA
Akbar, S., Iqbal, M., Saleem, R. S., & Roh-ul-Amin, M. (2026). Frequency of Drug-Induced Hepatotoxicity in Patients with HIV/Tuberculosis Coinfection Receiving Antiretroviral and Anti-Tuberculosis Therapy. Pakistan Journal of Medical Sciences, 42(12), 3686-3689. https://doi.org/10.12669/pjms.42.12.19876
Vancouver
Akbar S, Iqbal M, Saleem RS, Roh-ul-Amin M. Frequency of Drug-Induced Hepatotoxicity in Patients with HIV/Tuberculosis Coinfection Receiving Antiretroviral and Anti-Tuberculosis Therapy. Pakistan Journal of Medical Sciences. 2026;42(12):3686-3689. doi:10.12669/pjms.42.12.19876
BibTeX
@article{Akbar2026,
author = {Akbar, Sehrish and Iqbal, Mujahid and Saleem, Rana Shahzad and Roh-ul-Amin, Mohammed},
title = {Frequency of Drug-Induced Hepatotoxicity in Patients with HIV/Tuberculosis Coinfection Receiving Antiretroviral and Anti-Tuberculosis Therapy},
journal = {Pakistan Journal of Medical Sciences},
year = {2026},
volume = {42},
number = {12},
pages = {3686--3689},
doi = {10.12669/pjms.42.12.19876}
}
EUVIMED